Immunology of Infectious Disease News Volume 9.18 | May 12 2021

    0
    36







    2021-05-12 | IIDN 9.18


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 9.18 – 12 May, 2021
    TOP STORY

    Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

    Across some heterogeneity in tumor type, stage, and treatment, virus-exposed solid cancer patients displayed a dominant impact of SARS-CoV-2, apparent from the resemblance of their immune signatures to those for COVID-19+ non-cancer patients
    [Cancer Cell]

    Full ArticleGraphical Abstract
    Studying COVID-19 with ALI culture
    PUBLICATIONSRanked by the impact factor of the journal

    Neutralizing Antibody Responses to SARS-CoV-2 in Symptomatic COVID-19 Is Persistent and Critical for Survival

    The presence of neutralizing antibodies within the first weeks from symptoms onset correlated with time to a negative swab result, while the lack of neutralizing capacity correlated with an increased risk of a fatal outcome.
    [Nature Communications]

    Full Article

    Reverse-Transcribed SARS-CoV-2 RNA Can Integrate into the Genome of Cultured Human Cells and Can Be Expressed in Patient-Derived Tissues

    Scientists found target site duplications flanking the viral sequences and consensus LINE1 endonuclease recognition sequences at the integration sites, consistent with a LINE1 retrotransposon-mediated, target-primed reverse transcription and retroposition mechanism.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full ArticlePress Release

    SARS-COV-2 Antibody Dynamics and B-Cell Memory Response Over-Time in COVID-19 Convalescent Subjects

    SARS-CoV-2 spike-specific IgG memory B cells were evaluated in a randomly selected group of COVID-19 recovering subjects by reversed B-cell FluroSpot based on human IgG SARS-CoV-2 receptor-binding domain.
    [Clinical Microbiology and Infection]

    Full Article

    Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

    Researchers treated 50 patients with Severe combined immunodeficiency due to adenosine deaminase (ADA) with an investigational gene therapy composed of autologous CD34+ hematopoietic stem and progenitor cells transduced ex vivo with a self-inactivating lentiviral vector encoding human ADA.
    [New England Journal of Medicine]

    AbstractPress Release

    Immune Cellular Networks Underlying Recovery from Influenza Virus Infection in Acute Hospitalized Patients

    Investigators reported the dynamics of 18 important immune parameters, related to clinical, genetic and virological factors, in influenza patients across different severity levels.
    [Nature Communications]

    Full Article

    Genetically Edited CD34+ Cells Derived from Human iPS Cells In Vivo but Not In Vitro Engraft and Differentiate into HIV-Resistant Cells

    CD34+ cells derived in vitro from induced pluripotent stem (iPS) cells genetically modified to carry the CCR5Δ32 mutant alleles did not engraft in humanized immunodeficient mice.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Pertussis Immunization during Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm Born Infants

    The authors report its effect at birth and on antibody-mediated immune responses to a DTaP-IPV-HB-PRP~T vaccine in preterm compared to term infants.
    [Clinical infectious Diseases]

    Abstract

    IL-17 Mediates Protective Immunity against Nasal Infection with Bordetella pertussis by Mobilizing Neutrophils, Especially Siglec-F+ Neutrophils

    Researchers found significant infiltration of IL-17-secreting CD4+ tissue-resident memory T cells and Siglec-F+ neutrophils into the nasal tissue during primary infection with B. pertussis.
    [Mucosal Immunology]

    Full Article

    Hyaluronic Acid Is a Negative Regulator of Mucosal Fibroblast-Mediated Enhancement of HIV Infection

    Since inflammation is known to facilitate HIV sexual transmission, researchers investigated the role of hyaluronic acid in genital mucosal fibroblast-mediated enhancement of HIV infection.
    [Mucosal Immunology]

    Full Article

    Mitofusin-2 Boosts Innate Immunity through the Maintenance of Aerobic Glycolysis and Activation of Xenophagy in Mice

    Investigators showed that mitofusin-2, a mitochondrial fusion protein, promoted innate host defense through the maintenance of aerobic glycolysis and xenophagy via hypoxia-inducible factor-1α during intracellular bacterial infection.
    [Communications Biology]

    Full Article
    The Immunology Podcast is here. Find it wherever you get your podcasts.
    REVIEWS

    Prospects for Durable Immune Control of SARS-CoV-2 and Prevention of Reinfection

    The authors summarize the current understanding of immune responses to and immune control of SARS-CoV-2 and the implications for prevention of reinfection.
    [Nature Reviews Immunology]

    Full Article

    TTP-Mediated Regulation of mRNA Stability in Immune Cells Contributes to Adaptive Immunity, Immune Tolerance and Clinical App

    Scientists summarize the effects of TTP-mediated regulation of mRNA stability in dendritic cells (DCs), focusing on DC maturation and antigen presentation, T cell activation and differentiation, immune tolerance and inflammation.
    [RNA Biology]

    Abstract
    INDUSTRY AND POLICY NEWS

    How the World Failed to Curb COVID

    The World Health Organization (WHO) was too cautious in communicating the risks of COVID-19 early last year, according to the first major investigation of the global pandemic response. Had it been bolder, and had nations heeded its guidance, the pandemic might have been curtailed, say the authors of the report.
    [Nature News]

    Editorial

    Pfizer and BioNTech Receive First US Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

    Pfizer, Inc. and BioNTech SE announced that the FDA has expanded the Emergency Use Authorization for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in the US for use in this age group.
    [Pfizer, Inc.]

    Press Release

    How COVID Broke the Evidence Pipeline

    With the pandemic now deep into its second year, it’s clear the crisis has exposed major weaknesses in the production and use of research-based evidence- failures that have inevitably cost lives.
    [Nature News]

    Editorial
    FEATURED EVENT

    HIV Pathogenesis and Cure

    1 – 4 June, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Research Fellow – Vaccine Adjuvants for Cancer and Viruses

    Trinity College Dublin – Dublin, Republic of Ireland

    Associate Director – Vaccine Development

    Pfizer – Pearl River, New York, United States

    Postdoctoral Research Fellow – Precision Vaccine Program

    Boston Children’s Hospital – Boston, Massachusetts, United States

    Postdoctoral Position – T Follicular Helper Cell Differentiation

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Postdoctoral Position – Gene and Cell Therapy Development for Treatment of Primary Immune Deficiencies

    NIH National Institute of Allergy and Infectious Diseases – Bethesda, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter